Philip Calder,Robert Grimble,Patrick Gallagher,Cliff Shearman
申请号：
US10979751
公开号：
US08729124B2
申请日:
2004.11.02
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The invention is directed to a method for preventing cerebral damage in patients having symptoms of atherosclerosis of arteries supplying the brain by administering to the patient a therapeutically effective amount of a composition comprising eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) or a combination thereof.
